MedPath

Comparison of Two Multifocal Contact Lenses

Not Applicable
Completed
Conditions
Presbyopia
Interventions
Device: Lotrafilcon B contact lens
Device: Comfilcon A contact lens
Registration Number
NCT01250054
Lead Sponsor
CIBA VISION
Brief Summary

The purpose of this study is to compare two multifocal contact lenses in presbyopic wearers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • At least 35 years of age.
  • Sign written Informed Consent
  • Spectacle add of +0.50 to +2.50D.
  • Best corrected visual acuity of at least 20.30 in both eyes.
  • Currently wearing soft contact lenses at least 5 days per week.
  • Other protocol-defined inclusion criteria may apply.
Exclusion Criteria
  • Eye injury or surgery within twelve weeks of enrollment.
  • Currently enrolled in any clinical trial.
  • Astigmatism > 1.00D.
  • Strabismus/amblyopia.
  • Other protocol-defined exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Lotrafilcon B / Comfilcon ALotrafilcon B contact lensLotrafilcon B multifocal contact lenses worn first, with comfilcon A multifocal contact lenses worn second. Each product worn bilaterally on a daily wear basis for one week.
Comfilcon A /Lotrafilcon BComfilcon A contact lensComfilcon A multifocal contact lenses worn first, with lotrafilcon B multifocal contact lenses worn second. Each product worn bilaterally on a daily wear basis for one week.
Lotrafilcon B / Comfilcon AComfilcon A contact lensLotrafilcon B multifocal contact lenses worn first, with comfilcon A multifocal contact lenses worn second. Each product worn bilaterally on a daily wear basis for one week.
Comfilcon A /Lotrafilcon BLotrafilcon B contact lensComfilcon A multifocal contact lenses worn first, with lotrafilcon B multifocal contact lenses worn second. Each product worn bilaterally on a daily wear basis for one week.
Primary Outcome Measures
NameTimeMethod
Overall VisionOne week of wear

Overall vision, as interpreted by the participant and recorded by the investigator as a single, retrospective evaluation of one week's wear time. Overall vision was measured on a 10-point scale, with 1 being worst and 10 being best.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath